PM
EW icon

Parametrica Management’s Edwards Lifesciences EW Stock Holding History

Parametrica Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,574
Closed -$247K – 111
2020
Q2 		$247K Sell
3,574
-1,355
-27% -$96.3K 0.27% 89
2020
Q1 		$310K Buy
+4,929
New +$355K 0.31% 88
2016
Q3 		– Sell
-7,572
Closed -$252K – 168
2016
Q2 		$252K Buy
+7,572
New +$259K 0.38% 135

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parametrica Management's EW Position: Q3 2020 in Review

Parametrica Management sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 3,574 shares — an estimated $247K sold.

Parametrica Management first reported a position in EW in Q2 2016 and held it in 3 quarters. The position peaked at $310K in Q1 2020. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Parametrica Management reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • Parametrica Management sold 3,574 Edwards Lifesciences shares in Q3 2020, an estimated $247K.
  • Parametrica Management first reported a position in Edwards Lifesciences in Q2 2016 and held it in 3 quarters.
  • Parametrica Management's Edwards Lifesciences position peaked at $310K in Q1 2020.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Parametrica Management's 13F filing for Q3 2020, filed 13 Nov 2020.